[
  {
    "info": {
      "NCT": "NCT04793958",
      "Protocol_No": "849-010",
      "jit": "Caris",
      "trial_name": "Mirati Therapeutics 849-010"
    },
    "disease": {
      "summary": "Advanced Metastatic Colorectal Cancer",
      "details": [
        {
          "code": "Bowel (BOWEL)",
          "selection": "include"
        }
      ]
    },
    "query": {
      "nct": "NCT04793958",
      "title": "Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)",
      "current_status": "Recruiting",
      "status_verif_date": "August 2022",
      "last_update_date": "August 30, 2022",
      "trial_hold_status": "open",
      "sponsor": "Mirati Therapeutics Inc.",
      "brief_summary": "Study 849-010 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab versus chemotherapy in the second-line treatment setting in patients with CRC with KRAS G12C mutation.",
      "conditions": "Advanced Colorectal Cancer | Metastatic Colorectal Cancer",
      "type": "Interventional",
      "phase": "Phase 3",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "MRTX849 + Cetuximab",
          "drug": "MRTX849 | Cetuximab",
          "arm_type": "Experimental",
          "line_of_therapy": "1",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "MRTX849 + Cetuximab",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "mFOLFOX6 or FOLFIRI",
          "drug": "mFOLFOX6 Regimen | FOLFIRI Regimen",
          "arm_type": "Active Comparator",
          "line_of_therapy": "1",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "mFOLFOX6 or FOLFIRI",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        }
      ],
      "docs": "Q:/MCK/MOA/Precision Oncology/JIT Trials/CarisPharmatechStudyList_2022-07-12.pdf",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04793958\" target=\"_blank\">NCT04793958<\/a>"
    }
  }
]
